Sign in
CompletedNo phase

High Flow Nasal Cannula Therapy for Childhood OSA

Key facts

Who runs it
Chinese University of Hong Kong
Where
Hong Kong1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
32 people enrolled
Started
1 Jul 2019
Ended
31 May 2024
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • High flow nasal cannula
  • Continuous positive airway pressure
Record updated
7 June 2024

Who can take part

Age
6 years to 18 years
Sex
Women and men
Healthy volunteers
Cannot take part
Show the full registry criteria (8)Hide the full registry criteria

Who can take part

  • Diagnosis of moderate-to-severe OSA requiring CPAP therapy (Moderate-to-severe OSA is defined as an OAHI ≥ 5 events per hour and reported history of habitual snoring of 3 nights or more per week)

Who cannot take part

  • Prior use of PAP or HFNC therapy
  • Syndromal diseases
  • Pathological central apnoea, chronic respiratory failure or neuromuscular disease as they would require bilevel PAP
  • Secondary obesity e.g. Prader-Willi syndrome, Cushing's syndrome
  • History of pneumothorax or pneumomediastinum
  • Cranio-facial anomalies
  • Refusal to use non-invasive ventilation

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The main objective of this study is to evaluate the efficacy of high-flow nasal cannula (HFNC) therapy in children with OSA.

Read full original descriptionShow less

Children and adolescents aged 6 to 18 years old with a diagnosis of moderate-to-severe OSA requiring CPAP therapy will be recruited.

In phase 1 study, eligible subject will be recruited for HFNC therapy titration with PSG to assess treatment efficacy. After titration, if HFNC therapy is shown to be effective, the participants will be recruited into the phase 2 intervention period to evaluate the compliance and quality of life with HFNC therapy. At baseline and follow-up visits, neurobehavioural and quality of life surveys will be completed, compliance data will be obtained.

The 2 groups in the trial

  • High flow nasal cannula (HFNC)Treatment being tested

    High flow nasal cannula therapy

    Treatment: High flow nasal cannula

  • Continuous positive airway pressure (CPAP)Existing treatment, for comparison

    Continuous positive airway pressure therapy

    Treatment: Continuous positive airway pressure

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
High-flow Nasal Cannula as an Alternative Intervention for Children and Adolescents With Obstructive Sleep Apnoea
Publications
Record updated
7 June 2024